3
Orphan Designations
0
FDA Approvals
8
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| Char syndrome | Trastuzumab vedotin | Orphan Designation | - |
| Mallory-Weiss syndrome | Trastuzumab vedotin | Orphan Designation | - |
| carbon monoxide-induced delayed encephalopathy | Trastuzumab vedotin | Orphan Designation | - |
| gastroesophageal junction adenocarcinoma | Trastuzumab vedotin | Orphan Designation | - |
| malignant pancreatic neoplasm | recombinant humanized anti-human tissue factor monoclonal antibody conjugated with a cytotoxic small molecule MMAE | Orphan Designation | - |
| multisystemic smooth muscle dysfunction syndrome | Trastuzumab vedotin | Orphan Designation | - |
| nasopharyngeal carcinoma | Recombinant humanized anti-human epidermal growth factor receptor monoclonal antibody conjugated to monomethyl auristatin E | Orphan Designation | - |
| natal teeth-intestinal pseudoobstruction-patent ductus syndrome | Trastuzumab vedotin | Orphan Designation | - |